Drug
Biological Ntla 2002
Biological Ntla 2002: highest development phase Phase 1/2, developed by Intellia Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Intellia Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Biological NTLA-2002 NCT05120830 | Phase 1/2 | Hereditary Angioedema |
Latest
No recent events.
Follow Biological Ntla 2002 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.